Rare cancer hope: genetic tests may match patients to better treatments
NCT ID NCT04504604
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether genetic testing of tumors and blood can help doctors choose better treatments for people with rare cancers. About 400 adults with rare solid tumors or lymphomas will have their tumors genetically analyzed. A team of experts will review the results and recommend personalized therapies. The goal is to see if this approach improves how long patients live without their cancer getting worse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FoundationOne CDx and FoundationOne Liquid CDx (diagnostic tests)
What this could lead to
If successful, this could show that personalized treatment based on genetic testing improves outcomes for people with rare cancers.
What could go wrong
This is an early-stage study with no control group, so results may not prove effectiveness. The approach may not work for all rare cancer types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
TargetCancer Foundation
RECRUITINGCambridge, Massachusetts, 02139, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact